L.P. Bos

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 193 citations · Full text

Inflammation, Autoimmune Disease, Hematology +7

Pharmacokinetics of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease

Luc J. J. Derijks, Lennard P. L. Gilissen, L.G.J.B. Engels et al. · Therapeutic Drug Monitoring · 2004 · 121 citations

Red Blood Cell, Gastrointestinal Pharmacology, Tpmt Genotype +8

High incidence of inflammatory bowel disease in The Netherlands

M.G.V.M. Russel, Elisabeth Dorant, A. Volovics et al. · Diseases of the Colon & Rectum · 1998 · 96 citations

Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms

Mariëlle Romberg‐Camps, M. Hesselink, Leo J. Schouten et al. · Journal of Crohn s and Colitis · 2009 · 79 citations · Full text

Erythrocytapheresis versus phlebotomy in the initial treatment of HFE hemochromatosis patients: results from a randomized trial

Eva Rombout‐Sestrienkova, Fred Nieman, Brigitte A.B. Essers et al. · Transfusion · 2011 · 75 citations